[Clinical Features of the Metabolic Syndrome in Patients with Polycystic Ovary Syndrome].

Wei-hong Hu,Jie Qiao,Li-na Wang,Jun Tong
DOI: https://doi.org/10.3969/j.issn.1671-167x.2010.02.010
2010-01-01
Abstract:OBJECTIVE:To study characteristics of the metabolic syndrome (MS) in patients with polycystic ovary syndrome (PCOS) according to 2004 Diagnostic Criteria by the Chinese Diabetes Society (CDS).METHODS:A 75 g oral glucose tolerance test (OGTT) with plasma glucose and serum insulin (INS) levels was performed in 232 PCOS patients. Also, serum triglycerides (TG), total cholesterol (TC), high density lipoprotein (HDL) cholesterol and low density lipoprotein (LDL) cholesterol (HDL-C and LDL-C) were measured.RESULTS:The rates of MS prevalence was 31.9% (74/232) in patients with PCOS. The rate of hyperglycaemia, high blood pressure, obesity and lipid metabolic disturbance were 30.6% (71/232), 5.6% (13/232), 48.3% (112/232) and 48.3% (112/232), respectively. The rate of MS prevalence and all metabolic parameters were higher in obese than in non-obese patients with PCOS. Age, BMI and all metabolic parameters were higher in PCOS patients with MS than in those without MS.CONCLUSION:According to the CDS criteria, the rate of MS prevalence was lower than that of the West in our study, and similar to that of some Asian countries. MS prevalence increased with age and BMI in patients with PCOS.
What problem does this paper attempt to address?